LegoChem and Takeda enter research licensing agreement to evaluate next-generation ADC candidates Jan. 12, 2017
Scancell announces final clinical study report on phase I/II trial of SCIB-1 in melanoma Jan. 3, 2017
Phase II study of trastuzumab emtansine in HER2-positive UBC or metastatic pancreas/cholangio cancer Jan. 3, 2017
RSS